Cargando…
Barriers towards the publication of academic drug trials. Follow-up of trials approved by the Danish Medicines Agency
OBJECTIVE: To characterize and quantify barriers towards the publication of academic drug trials. STUDY DESIGN: We identified academic drug trials approved during a 3-year period (2004–2007) by the Danish Medicines Agency. We conducted a survey among the trial sponsors to describe the rates of initi...
Autores principales: | Berendt, Louise, Petersen, Lene Grejs, Bach, Karin Friis, Poulsen, Henrik Enghusen, Dalhoff, Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423601/ https://www.ncbi.nlm.nih.gov/pubmed/28486523 http://dx.doi.org/10.1371/journal.pone.0172581 |
Ejemplares similares
-
From protocol to published report: a study of consistency in the reporting of academic drug trials
por: Berendt, Louise, et al.
Publicado: (2016) -
Simvastatin and oxidative stress in humans: A randomized, double-blinded, placebo-controlled clinical trial
por: Rasmussen, Sanne Tofte, et al.
Publicado: (2016) -
Prevalence of Potential Pathogenic and Antimicrobial Resistant Escherichia coli in Danish Broilers
por: Poulsen, Louise Ladefoged, et al.
Publicado: (2023) -
The European Medicines Agency's approval of new medicines for type 2 diabetes
por: Blind, Eberhard, et al.
Publicado: (2018) -
Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World
por: Fernández-Garza, Luis E., et al.
Publicado: (2023)